Health Canada approves new Eli Lilly GLP-1 pill for weight loss
Eli Lilly's Foundayo is also approved to help treat Type 2 diabetes.
Health Canada has granted approval for a new GLP-1 medication, Eli Lilly's Foundayo, for weight loss purposes. Unlike weekly injections, Foundayo is a daily pill taken by adults with obesity and those who are overweight with a related medical condition like high blood pressure or sleep apnea. In addition to aiding weight loss, Foundayo is also approved for treating Type 2 diabetes.
Produced by Eli Lilly, Foundayo contains the active ingredient orforglipron, a non-peptide GLP-1 receptor agonist. It's similar in effectiveness to semaglutide and tirzepatide, which are active ingredients in injectable drugs Mounjaro, Zepbound, Ozempic, and Wegovy, manufactured by competitor Novo Nordisk. GLP-1 medications, including Foundayo, have been a game-changer in weight-loss treatment, with some patients possibly preferring the convenience of a pill over injections.
Despite being already on the market in Canada, Novo Nordisk's Rybelsus is specifically for Type 2 diabetes management and not weight loss. Foundayo's smaller molecule orforglipron can be orally consumed and absorbed without digestion, potentially offering the same, if not better, results for weight loss compared to its counterparts.
However, the side effects of GLP-1 medications, both injectable and oral, often include gastrointestinal issues such as nausea or vomiting. Dr. Ehud Ur, an endocrinologist, has not yet seen clinical trial results on Foundayo's potential cardiovascular benefits, similar to semaglutide and tirzepatide. Health Canada approved Foundayo on November 13, with Eli Lilly's spokesperson expecting it to be available in pharmacies by January.
Novo Nordisk's Wegovy pill, awaiting approval, could soon join Foundayo in Canada's weight-loss pill options.
Written by urgent.news from Global News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Health Canada approves Eli Lilly’s GLP-1 pill for weight loss winnipegfreepress.com